Trade Setup Buy Target $1.52 Sell Target $1.73 Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. It markets dermatology products, such as Targadox for acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; Ala-Scalp and Triderm, which are used for the inflammatory […]
Read MorePlus, U.K. Prime Minister Johnson is facing difficulties in getting his Brexit deal through Parliament, and Boeing is facing fresh criticism on its handling of the 737 Max scandal.
Read MoreThese 3 top picks could see major upside ahead.
Read MoreTrade Setup Buy Target $151.25 or better Sell Target – TradersPro Sell Signal McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well […]
Read MoreTrade Setup Buy Target – $2.25 or better Sell Target – TradersPro Sell Signal Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat […]
Read MoreYears ago, as I began my career as an investor, I read a book by Peter Lynch. Mr. Lynch had made his name, and his fortune, as the manager of Fidelity’s flagship Magellan fund in the late /70’s and ’80’s, and his incredible performance was one of the big reasons Magellan, at the time, was […]
Read MoreProgress on the trade front has given the market a new set of momentum over the past couple of weeks – enough that the major indices are nearing the all-time highs they set at the end of July. Even so, the unpredictability associated with tariff news and the trade war itself has resulted in a […]
Read MoreTrade Setup Buy Target – $2.70 or better Sell Target – TradersPro Sell Signal Generex Biotechnology Corporation, through its subsidiaries, primarily engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an insulin formulation administered as […]
Read MoreAlexion Pharmaceuticals Inc. (ALXN) has had an abysmal run over just the last two sessions. While Friday saw the biotech — known for developing Soliris, a treatment for atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH) — become the S&P 500’s second-worst performer that session, the stock outdid itself during Tuesday’s session by […]
Read MoreThe market jumped on positive news on the trade war front this morning. Plus, Tesla raises prices in China, Johnson & Johnson awaits a verdict, and vegan fried chicken could soon be available at a KFC near you.
Read MoreSan Fransisco Fed President Mary Daly says so. Also, Target and Lowe’s deliver earnings beats, more Fed news, and the CBO’s latest budget report.
Read MoreTrade Setup Buy Target $37.79 Sell Target $39.36 Stop Loss $35.34 Weis Markets, Inc. engages in the retail sale of food in Pennsylvania and surrounding states. The company’s retail food stores sell groceries, dairy products, frozen foods, meats, seafood, fresh produce, floral, pharmacy services, deli products, prepared foods, bakery products, beer and wine, and fuel; […]
Read MoreTrade Setup Buy Target $4.01 Sell Target $4.69 Trailing Stop 20% BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to […]
Read MoreBuy Target $2.78 Sell Target $3.24 Trailing Stop 20% AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company also develops ZALVISO, a […]
Read MoreOne of the most underwhelming sectors in this market this year has been Healthcare. As measured by the S&P 500 Healthcare Sector SPDR ETF (XLV), the sector is up just about 6.5% year to date, while the broad market hit a new all-time high earlier and is up a little over 19% since the beginning […]
Read More